Financial comparisons Genmab A/S Nasdaq

Stocks

GMAB

US3723032062

Biotechnology & Medical Research

Market Closed - Nasdaq 00:00:00 13/06/2026 +04 5-day change 1st Jan Change
25.08 USD -0.63% Intraday chart for Genmab A/S -0.28% -18.57%
Main competitors
Revenues (Y-1) Net Margin (Y-1) EBIT Margin (Y-1) ROE (Y-1) ROA (Y-1) Leverage (Y-1)
4.23B 30.41%24.81%20.15%17.36%-3.18x
6.5B 42.13%52.64%28.56%20.88%-0.99x
3.37B -39.59%-48.95%-5.88%-5.1%6.99x
606M -210.54%-205.59%-249.28% - 0.72x
3.12B 22.53%31.44%11.9%8.13%-1.19x
2.32B 33.73%37.59%35.53%27.02%-1.18x
294M -18.56%-24.05%-9.34%-9.05%8.22x
498M 32.27%31.52%16.97%14.74%-3.83x
958M -30.08%-31.31%-42.49% - 2.15x
829M -0.2%11.86%-0.5% - -6.61x
437M -36.42%-29.57%-7.45%-4.07%6.67x
88.04M -891.6%-695.44% - -55.55%0.05x
113M -310.18%-226% - - -
463M 21.89%22.29%25.37%11.13%2.45x
1.16B 23.46%22.49%20.46%11.16%0.73x
1.79B 6.64%9.69%4.89%1.76%4.17x
Average 1.67B -82.76% -63.54% -10.79% 3.2% 1.01x
Weighted average by Cap. 2.81B -44.3% -33.7% -9.64% 8.86% 0.22x
Bio Therapeutic Drugs
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!